Continuous glucose monitor from Medtronic wins EU approval

12/5/2012 | Star Tribune (Minneapolis-St. Paul, Minn.)

Medtronic has earned CE mark approval to market its Sentrino device in Europe. The technology, which is used to monitor a patient's glucose levels continuously and less invasively, is billed as the first such device designed for use in hospital critical care units.

View Full Article in:

Star Tribune (Minneapolis-St. Paul, Minn.)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance Director
Abbott Laboratories
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA